skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms

Frontiers in oncology, 2021-02, Vol.10, p.578380-578380 [Peer Reviewed Journal]

Copyright © 2021 Exner, Arrey, Prasad and Grötzinger. ;COPYRIGHT 2021 Frontiers Research Foundation ;Copyright © 2021 Exner, Arrey, Prasad and Grötzinger 2021 Exner, Arrey, Prasad and Grötzinger ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2020.578380 ;PMID: 33628728

Full text available

Citations Cited by
  • Title:
    mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
  • Author: Exner, Samantha ; Arrey, Gerard ; Prasad, Vikas ; Grötzinger, Carsten
  • Subjects: mTOR inhibitors ; neuroendocrine neoplasms ; Oncology ; peptide receptor radioligand therapy ; radiosensitizer ; signaling ; Tumors
  • Is Part Of: Frontiers in oncology, 2021-02, Vol.10, p.578380-578380
  • Description: Peptide receptor radioligand therapy (PRRT) has evolved as an important second-line treatment option in the management of inoperable and metastatic neuroendocrine neoplasms (NEN). Though high radiation doses can be delivered to the tumors, complete remission is still rare. Radiosensitization prior to PRRT is therefore considered to be a promising strategy to improve the treatment effect. In this study, effect and mechanism of mTOR inhibitors were investigated in a comprehensive panel of five NEN cell lines (BON, QGP-1, LCC-18, H727, UMC-11), employing assays for cellular proliferation, clonogenic survival, cell cycle modification and signaling. mTOR inhibition lead to growth arrest with a biphasic concentration-response pattern: a partial response at approximately 1 nM and full response at micromolar concentrations (8-48 µM). All cell lines demonstrated elevated p70S6K phosphorylation yet also increased phosphorylation of counterregulatory Akt. The pulmonary NEN cell line UMC-11 showed the lowest induction of phospho-Akt and strongest growth arrest by mTOR inhibitors. Radiation sensitivity of the cells (50% reduction versus control) was found to range between 4 and 8 Gy. Further, mTOR inhibition was employed together with irradiation to evaluate radiosensitizing effects of this combination treatment. mTOR inhibition was found to radiosensitize all five NEN cells in an additive manner with a moderate overall effect. The radiation-induced G2/M arrest was diminished under combination treatment, leading to an increased G1 arrest. Further investigation involving a suitable animal model as well as radioligand application such as Lu-DOTATATE or Lu-DOTATOC will have to demonstrate the full potential of this strategy for radiosensitization in NEN.
  • Publisher: Switzerland: Frontiers Research Foundation
  • Language: English
  • Identifier: ISSN: 2234-943X
    EISSN: 2234-943X
    DOI: 10.3389/fonc.2020.578380
    PMID: 33628728
  • Source: Geneva Foundation Free Medical Journals at publisher websites
    PubMed Central
    Alma/SFX Local Collection
    ROAD: Directory of Open Access Scholarly Resources
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait